Skip to main content
Journal cover image

MAJOR BLEEDING IN PATIENTS WITH EMBOLIC STROKE OF UNDETERMINED SOURCE TREATED WITH DABIGATRAN VERSUS ACETYLSALICYLIC ACID (RE-SPECT ESUS TRIAL)

Publication ,  Conference
Granger, CB; Diener, H-C; Sacco, R; Easton, J; Cronin, L; Fräßdorf, M; Grauer, C; Brueckmann, M
Published in: Journal of the American College of Cardiology
March 2019

Duke Scholars

Published In

Journal of the American College of Cardiology

DOI

ISSN

0735-1097

Publication Date

March 2019

Volume

73

Issue

9

Start / End Page

1757 / 1757

Publisher

Elsevier BV

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Granger, C. B., Diener, H.-C., Sacco, R., Easton, J., Cronin, L., Fräßdorf, M., … Brueckmann, M. (2019). MAJOR BLEEDING IN PATIENTS WITH EMBOLIC STROKE OF UNDETERMINED SOURCE TREATED WITH DABIGATRAN VERSUS ACETYLSALICYLIC ACID (RE-SPECT ESUS TRIAL). In Journal of the American College of Cardiology (Vol. 73, pp. 1757–1757). Elsevier BV. https://doi.org/10.1016/s0735-1097(19)32363-0
Granger, Christopher B., Hans-Christoph Diener, Ralph Sacco, J. Easton, Lisa Cronin, Mandy Fräßdorf, Claudia Grauer, and Martina Brueckmann. “MAJOR BLEEDING IN PATIENTS WITH EMBOLIC STROKE OF UNDETERMINED SOURCE TREATED WITH DABIGATRAN VERSUS ACETYLSALICYLIC ACID (RE-SPECT ESUS TRIAL).” In Journal of the American College of Cardiology, 73:1757–1757. Elsevier BV, 2019. https://doi.org/10.1016/s0735-1097(19)32363-0.
Granger CB, Diener H-C, Sacco R, Easton J, Cronin L, Fräßdorf M, et al. MAJOR BLEEDING IN PATIENTS WITH EMBOLIC STROKE OF UNDETERMINED SOURCE TREATED WITH DABIGATRAN VERSUS ACETYLSALICYLIC ACID (RE-SPECT ESUS TRIAL). In: Journal of the American College of Cardiology. Elsevier BV; 2019. p. 1757–1757.
Granger, Christopher B., et al. “MAJOR BLEEDING IN PATIENTS WITH EMBOLIC STROKE OF UNDETERMINED SOURCE TREATED WITH DABIGATRAN VERSUS ACETYLSALICYLIC ACID (RE-SPECT ESUS TRIAL).” Journal of the American College of Cardiology, vol. 73, no. 9, Elsevier BV, 2019, pp. 1757–1757. Crossref, doi:10.1016/s0735-1097(19)32363-0.
Granger CB, Diener H-C, Sacco R, Easton J, Cronin L, Fräßdorf M, Grauer C, Brueckmann M. MAJOR BLEEDING IN PATIENTS WITH EMBOLIC STROKE OF UNDETERMINED SOURCE TREATED WITH DABIGATRAN VERSUS ACETYLSALICYLIC ACID (RE-SPECT ESUS TRIAL). Journal of the American College of Cardiology. Elsevier BV; 2019. p. 1757–1757.
Journal cover image

Published In

Journal of the American College of Cardiology

DOI

ISSN

0735-1097

Publication Date

March 2019

Volume

73

Issue

9

Start / End Page

1757 / 1757

Publisher

Elsevier BV

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology